PARAGON-HF Response Score Calculator
Patient parameters
Enter baseline clinical and laboratory values.
Clinical context and limitations
PARAGON-HF compared sacubitril/valsartan with valsartan in patients with heart failure and LVEF of at least 45%. Its primary endpoint was total heart-failure hospitalizations and cardiovascular death—not a validated individual probability of response derived from the nine inputs in this calculator.
The supplied equation uses hand-assigned coefficients and a logistic transformation. The original template does not provide a derivation dataset, full regression specification, calibration assessment, discrimination statistics, or external validation. Therefore, its output cannot be interpreted as an evidence-based probability, risk category, or treatment recommendation.
Important distinctions
- Calculated output: arithmetic output from the legacy equation.
- Clinical interpretation: no validated interpretation or cutoff is established for this equation.
- Treatment decision: should be based on the patient's clinical profile, applicable guidelines, contraindications, tolerability, and shared decision-making—not this index.
About the trial evidence
PARAGON-HF did not demonstrate a statistically significant reduction in its primary composite endpoint in the overall trial population. Prespecified subgroup analyses suggested treatment-effect heterogeneity, including by sex and LVEF; these findings are not equivalent to validation of the score reproduced here.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.